MedTrace Logo

Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

NCT02602353 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2016-10-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the analgesic efficacy and safety of a new pain patch compared to placebo and no treatment in subjects experiencing Delayed Onset Muscle Soreness (DOMS).

Conditions

  • Delayed Onset Muscle Soreness

Interventions

DRUG

Loxoprofen Pain Patch

One Loxoprofen Pain Patch (active NSAID) applied once daily for 3 days

DRUG

Placebo Patch

One Placebo Patch applied daily for 3 days

DRUG

No Treatment

No Treatment for 3 days

Sponsors & Collaborators

  • Cardinal Health

    collaborator INDUSTRY

  • Lead Chemical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Derek Muse, MD · Jean Brown Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602353 on ClinicalTrials.gov